ERBB2 and neoplasm: According to other studies, the risk factors for LRR following IBR included certain histopathological subtypes (Luminal B-like/HER2 positive and Triple-negative), body mass index ≥ 25 [7], ER–negative status, age ≤ 40 years, and large tumor (T2 versus T1) [8].